BridgeBio Pharma, Inc. (NASDAQ:BBIO) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. lowered its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 5.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 64,869 shares of the company’s stock after selling 3,481 shares during the quarter. Mirae Asset Global Investments […]
More Stories
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
AXIS Capital Holdings Limited (NYSE:AXS) Receives Average Recommendation of “Moderate Buy” from Analysts
Shares of AXIS Capital Holdings Limited (NYSE:AXS – Get Free Report) have received an average rating of “Moderate Buy” from...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Cameco Co. (TSE:CCO) Receives C$84.30 Average PT from Brokerages
Shares of Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) have been assigned a consensus recommendation of “Buy” from the...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...
Brokerages Set Amgen Inc. (NASDAQ:AMGN) Price Target at $318.83
Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been assigned a consensus recommendation of “Hold” from the twenty-seven...